Cancer / Oncology
Qritive Partners with Roche to Transform Cancer Diagnostics with AI-Powered Pathology Solutions
Qritive, a leading digital pathology and AI company headquartered in Singapore, is proud to announce its collaboration with Roche, one of the largest ...
September 13, 2024 | News
Thermo Fisher Scientific Awards Oncomine Clinical Research Grants to Advance Global Oncology Diagnostics
Recipients’ research advances future development of oncology diagnostics, the impact of DNA quality on ovarian cancer outcomes and molecular diagnosi...
September 12, 2024 | News
Lunit Integrates AI Biomarker into Roche's navify® Platform, Boosting Precision in Cancer Biomarker Testing
Lunit's AI-powered biomarker, Lunit SCOPE PD-L1 TPS, integrates into Roche's navify® Digital Pathology platform to enhance precision medicine an...
September 10, 2024 | News
Daiichi Sankyo and AstraZeneca’s Datopotamab Deruxtecan Shows Superior Progression-Free Survival in Biomarker-Positive NSCLC Patients
Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan demonstrated meaningfully greater magnitude of progression-free survival benefit in p...
September 09, 2024 | News
Acepodia Partners with Pfizer Ignibiolote to Advance Cell Therapies for Autoimmune Diseases and Oncology
Through Pfizer Ignite, Acepodia will gain access to Pfizer's resources, scale and expertise as the company broadens the application of its platform beyon...
September 04, 2024 | News
Simcere Zaiming and TargetRx Forge Strategic Partnership for Groundbreaking ALK/ROS1 Dual Inhibitor in China
Simcere Zaiming, an innovative oncology company under Simcere Pharmaceutical Group (2096.HK), announced a collaboration agreement with Shenzhen TargetRx In...
September 03, 2024 | News
Noetik Secures $40M in Oversubscribed Series A to Advance AI-Driven Cancer Therapeutics
Noetik, an AI-native biotech company leveraging self-supervised machine learning and high-throughput spatial data to develop next-generation cancer therape...
September 02, 2024 | News
Guardant Health Japan Secures MHLW Approval for Guardant360® CDx as First Blood-Based Companion Diagnostic for EGFR Exon 20 NSCLC Mutations
Guardant Health Japan , a leading precision oncology company, announced that the Ministry of Health, Labour and Welfare (MHLW) in Japan&nbs...
August 30, 2024 | News
Zuellig Pharma Secures Exclusive Distribution Agreement with Regeneron to Launch Libtayo® in South Korea and Taiwan
Zuellig Pharma, a leading healthcare solutions company in Asia, has announced an exclusive distribution agreement with Regeneron Ireland DAC, a wholly owne...
August 28, 2024 | News
HKBU Research Identifies Phosphocholine as a Potential Therapy for PM2.5-Related Lung Damage
A research team led by Hong Kong Baptist University (HKBU) has discovered that phosphocholine, an important component in the body's metabolism, c...
August 28, 2024 | News
Everest Medicines Launches First Clinical Trial for Personalized mRNA Cancer Vaccine EVM16 in China
Everest Medicines , a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeut...
August 22, 2024 | News
GE HealthCare and Roche Diagnostics Partner to Transform Precision Cancer Care in Asia Pacific
GE HealthCare and Roche Diagnostics have entered into a Memorandum of Understanding (MOU) that will leverage the strengths and resources of both comp...
August 22, 2024 | News
Kelun-Biotech's NDA for Sacituzumab Tirumotecan Accepted by China's NMPA Following Positive Lung Cancer Study Results
New drug application (NDA) for the core product sacituzumab tirumotecan (sac-TMT, formerly SKB264/MK-2870) based on the positive results from the pivotal O...
August 21, 2024 | News
Boston Immune Technologies and Therapeutics Secures Strategic Agreement with Otsuka's MSRD and $4M NIH/NCI Grant for Advancing Antibody Development
Boston Immune Technologies and Therapeutics, Inc. (BITT), a clinical stage developer of novel tumor necrosis factor superfamily receptor (TNFSR) antagonist...
August 19, 2024 | News
Most Read
- Biotech and Biopharma Industry Trends: What to Watch for in 2024
- Revolutionizing Drug Discovery: 15 AI Companies to Watch in 2024
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2024
- 2024's Biopharma Roadmap: Top 24 Biopharma Trends to Watch in 2024
- Breakthroughs Unveiled: A Year of Groundbreaking Novel Drug Approvals in 2023
- Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024
Bio Jobs
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
- Cordlife Accelerates Lab and Technical Staff Recruitment to Rebuild Foundation and Strengthen Core Processes in Singapore
- Padraig McDonnell Takes Helm as Agilent Technologies' New CEO, Pledges to Elevate Scientific Impact
- Agilent Singapore and Malaysia Hosts CEO Transition Event: Celebrating Leadership and Welcoming New CEO
- Leica Microsystems Announces Vacancy for Senior Imaging FPGA Testing Engineer in Singapore
- Glen Godresse Takes Helm as CEO of Menarini Asia-Pacific
News
Editor Picks
